Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy

BACKGROUND: Cervical cancer patients with stage IVB, persistent, or recurrent disease after complete primary treatment are usually treated with systemic chemotherapy. Circulating blood components have been a target of study relative to their ability to predict cancer outcomes; however, no previous s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ittiamornlert, Pornprom, Ruengkhachorn, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329186/
https://www.ncbi.nlm.nih.gov/pubmed/30630439
http://dx.doi.org/10.1186/s12885-019-5269-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329186/
https://www.ncbi.nlm.nih.gov/pubmed/30630439
http://dx.doi.org/10.1186/s12885-019-5269-1

Ejemplares similares